JC
Therapeutic Areas
Harmony Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| WAKIX (pitolisant) | Narcolepsy (Adults) | Approved |
| ZYN002 (transdermal cannabidiol gel) | Developmental and Epileptic Encephalopathies (e.g., LGS) | Phase 3 |
| EPX-100 (clemizole) | Dravet Syndrome | Phase 1/2 |
| EPX-200 | Genetic Epilepsies | Preclinical |
Leadership Team at Harmony Biosciences
JM
Jeffrey M. Dayno, M.D.
President and Head of Research and Development
SK
Sandip Kapadia, CPA
Chief Financial Officer